- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06080087
Implementation Toolkit to Enhance EBP Among Marginalized Families
October 5, 2023 updated by: James Lee, Seattle Children's Hospital
Although the efficacy of early intervention (EI) for autistic children and their families has been established, many marginalized families with diverse cultural and linguistic backgrounds still report inequitable access to evidence-based practices (EBP).
There are several strategies to increase EBP implementation that are especially relevant to marginalized families who report inequitable access to coaching from EI providers, such as increasing the capacity of EI providers to coach families in a culturally responsive way.
However, EI providers are provided with limited professional development in both family coaching and cultural responsiveness, which results in perpetuation of EBP implementation failure.
Thus, it is crucial to develop and validate an implementation toolkit that comprises strategies to enhance cultural responsiveness in the uptake of EBPs among EI providers.
Therefore, the overall purpose of this research is to identify facilitators and barriers of EBP implementation among marginalized families in EI to aid the development an implementation toolkit with a focus on capacity building of EI providers to implement EBP with cultural responsiveness.
This will involve conducting individual interviews with EI providers.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Washington
-
Seattle, Washington, United States, 98115
- Seattle Children's Research Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
There are two sets of inclusion criteria for both types of participants.
Inclusion Criteria for EI providers:
- Currently working with minoritized families of young children within Part-C
- Willing to complete I-TEAM as instructed
- Over the age of 18
Exclusion Criteria for EI providers:
- Not able to complete I-TEAM as instructed
Inclusion Criteria for families:
- Having a minoritized backgrounds (e.g., migrant/refugee background, primarily speaks another language other than English at home)
- Having a young child eligible for early intervention services
Exclusion Criteria for EI providers:
- Not currently receiving early intervention services
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention
Intervention group will receive access to the I-TEAM
|
I-TEAM is a web-based implementation toolkit that supports to enhance cultural responsiveness of EI providers in their EBP delivery with minoritized families of young autistic children
|
|
No Intervention: Waitlist control
Waitlist control group will not receive access to the I-TEAM until the Intervention group has completed the 8-week intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Coaching Fidelity Scale (CFS)
Time Frame: Change from baseline at 8 weeks
|
CFS is an observational measure to assess coaching fidelity during an interaction between a coach and a learner
|
Change from baseline at 8 weeks
|
|
Cultural Self-Efficacy Scale for Early Interventionists (CSES-EI)
Time Frame: Change from baseline at 8 weeks
|
CSES-EI is a 32-item, self-reported measure of cultural self-efficacy of early intervention providers
|
Change from baseline at 8 weeks
|
|
Social Validity
Time Frame: Change from baseline at 8 weeks
|
We will measure acceptability and feasibility of I-TEAM
|
Change from baseline at 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measure of NDBI Strategy Implementation: Caregiver Change (MONSI-CC)
Time Frame: Change from baseline at 8 weeks
|
MONSI-CC is an observational measure that detects changes in caregivers' use of NDBI strategies in early intervention
|
Change from baseline at 8 weeks
|
|
Autism-specific parenting self-efficacy
Time Frame: Change from baseline at 8 weeks
|
We will use this self-reported tool to assess self-efficacy of parents of young autistic children
|
Change from baseline at 8 weeks
|
|
Social validity
Time Frame: Change from baseline at 8 weeks
|
We will assess social validity, including satisfaction with their services, reports of cultural responsiveness of their providers, acceptability of early intervention among intervention recipients
|
Change from baseline at 8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 30, 2023
Primary Completion (Estimated)
February 1, 2024
Study Completion (Estimated)
February 1, 2026
Study Registration Dates
First Submitted
July 9, 2023
First Submitted That Met QC Criteria
October 5, 2023
First Posted (Actual)
October 12, 2023
Study Record Updates
Last Update Posted (Actual)
October 12, 2023
Last Update Submitted That Met QC Criteria
October 5, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- STUDY00004246
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...Istituto Clinico HumanitasRecruitingAutism | Autism Spectrum Disorder (ASD) | Autism DisorderItaly
-
Istituto per la Ricerca e l'Innovazione BiomedicaRecruitingAutism | Autism DisorderItaly
-
University of NottinghamUniversity Hospitals of Derby and Burton NHS Foundation Trust; Lincolnshire...Not yet recruitingAutism Spectrum Disorder | Autism | Parent | Autism Disorder | Autism in Children | Parent Stress | Parent Mental Health | Autism Disorders and Maternal Stress | Parent SupportUnited Kingdom
-
Boston Children's HospitalRecruitingAutism Spectrum Disorder | Autism | Autism DisorderUnited States
-
Greater Atlanta Integrative PediatricsRecruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)United States
-
The Children's Hospital of Zhejiang University...Not yet recruitingAutism | Autism Spectrum Disorder (ASD)China
-
Poznan University of Physical EducationCompletedAutism | Autism Spectrum Disorder (ASD)Poland
-
Adia Med of Winter Park LLCRecruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)United States
-
Stanford UniversityJohn and Marcia Goldman FoundationNot yet recruitingAutism | Autism Spectrum Disorder (ASD)United States
-
Father Flanagan's Boys' HomeNational Institute on Deafness and Other Communication Disorders (NIDCD)Not yet recruitingAutism Spectrum Disorder | Autism | Autism, Susceptibility to, 6United States
Clinical Trials on I-TEAM
-
Thomas Jefferson UniversityUniversity of the Sciences in PhiladelphiaCompletedDiabetesUnited States
-
Washington University School of MedicineLogan UniversityCompletedChronic Pain | Spine DiseaseUnited States
-
The Hospital for Sick ChildrenEhave; Ontario Brain InstituteCompletedAttention-deficit Hyperactivity DisorderCanada
-
The Hospital for Sick ChildrenChild-Bright Network; Ehave; The Governors of the University of AlbertaCompletedADHD | ASD | CHD - Congenital Heart DiseaseCanada
-
McMaster UniversityCanadian Institutes of Health Research (CIHR); Ontario Ministry of Health and... and other collaboratorsCompleted
-
Qi-Yong LiCompletedBiliary Diseases | Pancreas DiseasesChina
-
Dana-Farber Cancer InstituteCompletedBreast Cancer | Gastrointestinal Cancer | Oral Cancer Directed Therapy | Oral ChemotherapyUnited States
-
University of PennsylvaniaNational Institute on Aging (NIA)CompletedSedentary Employees
-
Centers for Disease Control and PreventionCompleted
-
University of Colorado, DenverPatient-Centered Outcomes Research Institute; Mayo Clinic; University of Michigan and other collaboratorsCompletedCommunication DisabilitiesUnited States